Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Arthrogryposis-hyperkeratosis syndrome, lethal form is an arthrogryposis syndrome, described in two siblings to date, characterized by the association of multiple congenital joint contractures (of the large joints, fingers and toes) and hyperkeratosis (i.e. thick, scaling and fissured skin), with death occurring in early infancy. There have been no further reports in the literature since 1993.
Features include: Joint stiffness present at birth (arthrogryposis multiplex congenita).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 1 | Joint stiffness present at birth (arthrogryposis multiplex congenita) |
Biomarker and diagnostic research for arthrogryposis-hyperkeratosis syndrome, lethal form has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for arthrogryposis-hyperkeratosis syndrome, lethal form.
182 publications have been identified in PubMed for arthrogryposis-hyperkeratosis syndrome, lethal form. Research spans Review / Meta-Analysis (39%), Case Report / Case Series (29%), and Basic Science / Preclinical (19%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 64 | 39% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
48 |
29% |
Laboratory research | 32 | 19% |
Disease patterns and progression | 8 | 5% |
Testing and diagnosis research | 6 | 4% |
New treatment approaches | 4 | 2% |
Clinical study results | 3 | 2% |
Other research | 1 | 1% |
Vogt B (2026). [PMID: 41798468](https://pubmed.ncbi.nlm.nih.gov/41798468/). *Cureus*. [Case Report / Case Series]
Cevering CK (2026). [PMID: 41445934](https://pubmed.ncbi.nlm.nih.gov/41445934/). *Neurology. Clinical practice*. [Review / Meta-Analysis]
Musante L (2026). [PMID: 41709284](https://pubmed.ncbi.nlm.nih.gov/41709284/). *Genome Med*. [Basic Science / Preclinical]
Stevens KJ (2026). [PMID: 31613505](https://pubmed.ncbi.nlm.nih.gov/31613505/). *Unknown Journal*. [Diagnostic / Biomarker]
Li H (2026). [PMID: 41909338](https://pubmed.ncbi.nlm.nih.gov/41909338/). *Cureus*. [Case Report / Case Series]
Deschamps N (2026). [PMID: 41911281](https://pubmed.ncbi.nlm.nih.gov/41911281/). *PLoS Negl Trop Dis*. [Case Report / Case Series]
Badero OJ (2026). [PMID: 41523716](https://pubmed.ncbi.nlm.nih.gov/41523716/). *Cureus*. [Case Report / Case Series]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Velardo D (2026). [PMID: 42211024](https://pubmed.ncbi.nlm.nih.gov/42211024/). *Front Genet*. [Case Report / Case Series]
Haenen K (2026). [PMID: 41701647](https://pubmed.ncbi.nlm.nih.gov/41701647/). *Fetal diagnosis and therapy*. [Case Report / Case Series]